Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

TAK-438 - CAS# 881681-01-2 onic Acid (hydrate) through Suppression of the HIF-1α/VEGF

SKU: 42014361587

4.1
USD105.00 USD145.00

Pay in 4 interest-free payments of $26.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Live Spec

TAK-438 - CAS# 881681-01-2 onic Acid (hydrate) through Suppression of the HIF-1α/VEGFTAK438, also known as Vonoprazan Fumarate, is a new medicine for treating acid related diseases with a novel mechanism of action called potassium competitive acid blockers (P CABs) which competitively inhibits the binding of potassium ions to H+, K+ ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. TAKECAB provides a strong and sustained acid secretion inhibitory effect. Product information

Store: lifelines-uk.org.uk · Domain: lifelines-uk.org.uk

Description

through Suppression of the HIF-1α/VEGF Signaling Pathway

Molecular Weight: 1915

InChiKey: IGRCWJPBLWGNPX-UHFFFAOYSA-N

which may result in the inhibition of repair of single-strand DNA breaks

TAK-438 - CAS# 881681-01-2 onic Acid (hydrate) through Suppression of the HIF-1α/VEGFTAK438, also known as Vonoprazan Fumarate, is a new medicine for treating acid related diseases with a novel mechanism of action called potassium competitive acid blockers (P CABs) which competitively inhibits the binding of potassium ions to H+, K+ ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. TAKECAB provides a strong and sustained acid secretion inhibitory effect. Product information

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products